Akebia Therapeutics, Inc. (AKBA) Q1 2026 Earnings Call

Investor webinar replay

Replay transcript excerpt

Day, and thank you for standing by. Welcome to Akebia's First Quarter twenty twenty six Financial Results Conference Call. At this time, all participants are in a listen only mode. After the speakers' presentation, there will be a question and answer session. To ask a question during the session, you will need to press 11 on your telephone. You will then hear an automated message advising your hand is raised. To withdraw your question, please press 11 again. Please be advised that today's conference is being recorded. I would now like to hand the conference over to your first speaker today, Mercedes Carrasco. Please go ahead. Thank you, and welcome to Akebia's First Quarter twenty twenty six Financial Results and Business Updates Conference Call. Please note that a press release was issued earlier today, Thursday, May 7, detailing our first quarter twenty twenty six financial results, and that release is available on the Investors section of our website. For your convenience, a replay of today's call will be available on our website after we conclude. Joining me for today's call, we have John Butler, Chief Executive Officer Nick Grund, Chief Commercial Officer and Eric Ostrovsky, Chief Financial and Chief Business Officer. Doctor. Steven Burke, our Chief Medical Officer, will also be available during Q and A. I'd like to remind everyone that this call includes forward looking statements. Each forward looking statement on this call is subject to risks and uncertainties that could cause actual results to differ materially from those described in these statements. Additional information describing these risks is included in the financial results press release that we issued on May 7, as well as in the Risk Factors and Management Discussion and Analysis section of our mo...